BNT162b2 COVID-19 vaccination uptake, safety, effectiveness and waning in children and young people aged 12-17 years in Scotland

• Asıl Yazarlar: Igor Rudan (Yazar), Tristan Millington (Yazar), Karen Antal (Yazar), Zoe Grange (Yazar), Lynda Fenton (Yazar), Christopher Sullivan (Yazar), Audrey Buelo (Yazar), Rachael Wood (Yazar), Lana Woolford (Yazar), Olivia V. Swann (Yazar), Josephine L.K. Murray (Yazar), Lucy A. Cullen (Yazar), Emily Moore (Yazar), Fasih Haider (Yazar), Fatima Almaghrabi (Yazar), Jim McMenamin (Yazar), Utkarsh Agrawal (Yazar), Syed Ahmar Shah (Yazar), Steven Kerr (Yazar), Colin R. Simpson (Yazar), Srinivasa Vittal Katikireddi (Yazar), Sir Lewis D. Ritchie (Yazar), Chris Robertson (Yazar), Sir Aziz Sheikh (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2022-12-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Summary: Background: The two-dose BNT162b2 (Pfizer-BioNTech) vaccine has demonstrated high efficacy against COVID-19 disease in clinical trials of children and young people (CYP). Consequently, we investigated the uptake, safety, effectiveness and waning of the protective effect of the BNT162b2 agai...